Bayer AG (BAYZF.PK) News Headlines

▮ More

Date

Headline

5/10/2022 1:49:01 AM Bayer Group Q1 Profit Rises, Sales Up 14.3%; Confirms FY Currency-adj. Outlook

5/10/2022 1:33:46 AM Bayer Q1 EPS EUR 3.35; Core EPS EUR 3.53

3/10/2022 4:01:36 AM Bayer To Sell Environmental Science Professional Unit To Cinven In $2.6 Bln Deal

3/10/2022 3:41:09 AM Bayer To Sell Environmental Science Professional Business To Cinven For $2.6 Bln

3/1/2022 6:11:48 AM Bayer Q4 Profit Climbs, Sees Significant Growth In FY22; Stock Up

3/1/2022 1:58:24 AM Bayer Group Q4 Profit Climbs; Expects Significant Increase In 2022 Sales, Earnings

3/1/2022 1:34:13 AM Bayer Q4 EPS EUR 1.18; Core EPS EUR 1.26

2/18/2022 3:46:22 AM Bayer To Make Darolutamide Available To Broad Spectrum Of Prostate Cancer Patients

2/18/2022 3:19:10 AM Bayer Expects Nubeqa Peak Sales To Be More Than $3.4 Bln

2/11/2022 9:06:37 AM Regeneron: Phase 2 Data In Wet AMD Shows Potential Of Aflibercept 8 Mg Compared To EYLEA

2/4/2022 7:37:48 AM Bayer Discontinues Clinical Development Candidate Eliapixant

1/10/2022 4:41:31 AM Bayer Gains Access To Mammoth Biosciences' Gene-editing Technology - Quick Facts

1/10/2022 4:24:26 AM Bayer, Mammoth Biosciences Announce Strategic Collaboration Deal For Use Of Mammoth’s CRISPR Systems

12/3/2021 2:19:14 AM Orion: Phase III Trial With Darolutamide Meets Primary Endpoint In MHSPC

12/3/2021 1:55:52 AM Orion : ARASENS Trial With Darolutamide, Docetaxel And ADT Meets Primary Goal On Prostate Cancer

11/9/2021 1:46:07 AM Bayer Group Q3 Profit Rises, Sales Up 14.3%; Revises Outlook - Quick Facts

11/9/2021 1:31:49 AM Bayer Q3 Group Sales Up 14.3% On Currency & Portfolio-adj Basis,Fx & Portfolio Adj., To EUR 9.78 Vln

10/5/2021 3:31:17 AM Bayer Announces Investment In New Production Capabilities For Reversible Contraceptives

10/5/2021 3:05:46 AM Bayer To Invest Over EUR 400 Mln To Increase Access To Modern Contraception By 2030

10/4/2021 6:48:10 AM Bayer Recalls Specific Lotrimin And Tinactin Spray Products

Bayer Ag (BAYZF.PK)